Yellowbird Diagnostics logo

About us

Yellowbird Diagnostics develops plug-and-play imaging dyes for common medical imaging procedures. Our solutions enable better diagnostic imaging for patients with the greatest need for early diagnosis of diseases of the brain, heart and kidneys. Our products reveal otherwise invisible hallmarks of disease, empowering clinicians to make earlier and more effective medical decisions. Our molecular imaging dyes and platforms have been purpose-built to fill the current gap in diagnostic imaging of the brain, heart, and kidneys.

Program engagement

Yellowbird Diagnostics

Leadership

Nicholas D. Calvert

Co-Founder and CEO

Adam J. Shuhendler

Co-Founder and CSO

Alexia Kirby

Co-Founder and COO

Status

Intellectual Property

Fundraising

Sector

Subsector

Synapse Life Science Pitch Competition applications open. Apply by November 10, 2024

Applications for the 2025 Synapse Competition are open!

The Synapse Life Science Competition combines the ideas and research of life science innovators with the intellect and strategy of students. Finalists receive training, mentorship, a $2,000 grant and a chance to pitch and compete for BIG cash prizes!

Applications close on November 10, 2024.